Prediction of clinical outcomes in primary biliary cirrhosis by serum enhanced liver fibrosis assay
暂无分享,去创建一个
A. West | J. Boyer | B. Adams-Huet | J. Lake | M. Contos | V. Luketic | W. Rosenberg | J. Parkes | M. Peters | N. Bass | B. Combes | G. Garcia‐Tsao | R. Markin | T. Boyer | A. D. Di Bisceglie | R. Rubin | R. Butsch | D. Barnes | M. Mayo | A. S. Mills | D. Wheeler | E. Martínez | Yonas Getachew | S. Saldaña | A. Mills
[1] I. Guha,et al. Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers , 2007, Hepatology.
[2] T. Therneau,et al. The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD , 2007, Hepatology.
[3] C. Corless,et al. Assessment of FIBROSpect II to detect hepatic fibrosis in chronic hepatitis C patients. , 2007, The American journal of medicine.
[4] I. Guha,et al. Future use of the Glasgow alcoholic hepatitis score. , 2006, Gut.
[5] I. Guha,et al. Non-invasive markers associated with liver fibrosis in non-alcoholic fatty liver disease , 2006, Gut.
[6] John McHutchison,et al. Fibrosis as an end point for clinical trials in liver disease: a report of the international fibrosis group. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[7] Y. Ngo,et al. A prospective analysis of the prognostic value of biomarkers (FibroTest) in patients with chronic hepatitis C. , 2006, Clinical chemistry.
[8] V. de Lédinghen,et al. Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease , 2006, BMC gastroenterology.
[9] A. West,et al. Methotrexate (MTX) plus ursodeoxycholic acid (UDCA) in the treatment of primary biliary cirrhosis , 2005, Hepatology.
[10] D. Thabut,et al. Biomarkers for the prediction of liver fibrosis in patients with chronic alcoholic liver disease. , 2005, Clinical Gastroenterology and Hepatology.
[11] F. Carrat,et al. The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis. , 2005, Gastroenterology.
[12] D. Schuppan,et al. Serum markers detect the presence of liver fibrosis: a cohort study. , 2004, Gastroenterology.
[13] E. Dickson,et al. Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis) , 1978, Virchows Archiv A.
[14] T. Poynard,et al. Biochemical Markers of Fibrosis in Patients with Chronic Hepatitis C: A Comparison with Prothrombin Time, Platelet Count, and Age–Platelet Index , 2004, Digestive Diseases and Sciences.
[15] V. Paradis,et al. Sampling variability of liver fibrosis in chronic hepatitis C , 2003, Hepatology.
[16] P. Scheuer. Liver biopsy size matters in chronic hepatitis: Bigger is better , 2003, Hepatology.
[17] M. Manns,et al. Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa‐2b and ribavirin , 2003, Hepatology.
[18] L. Skovgaard,et al. Serum levels of YKL-40 and PIIINP as prognostic markers in patients with alcoholic liver disease. , 2003, Journal of hepatology.
[19] K. Lindor,et al. When is liver biopsy needed in the diagnosis of primary biliary cirrhosis? , 2003, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[20] T. Poynard,et al. Biochemical markers of liver fibrosis: a comparison with historical features in patients with chronic hepatitis C , 2002, American Journal of Gastroenterology.
[21] S Chevret,et al. Biochemical markers of liver fibrosis in patients infected by hepatitis C virus: longitudinal validation in a randomized trial , 2002, Journal of viral hepatitis.
[22] T. Poynard,et al. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study , 2001, The Lancet.
[23] K. Lazaridis,et al. Primary biliary cirrhosis , 1998, Springer Netherlands.
[24] M. Garrido,et al. Accuracy of staging in primary biliary cirrhosis. , 1996, Journal of clinical pathology.
[25] K. Ishak,et al. Histological grading and staging of chronic hepatitis. , 1995 .
[26] F. BordaCelaya,et al. [Primary biliary cirrhosis]. , 1989, Anales de medicina interna.
[27] E. DeLong,et al. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. , 1988, Biometrics.
[28] B. Maharaj,et al. SAMPLING VARIABILITY AND ITS INFLUENCE ON THE DIAGNOSTIC YIELD OF PERCUTANEOUS NEEDLE BIOPSY OF THE LIVER , 1986, The Lancet.
[29] H. Popper,et al. Nonsuppurative destructive chronic cholangitis and chronic hepatitis. , 1970, Progress in liver diseases.